Phase 4 Macular Degeneration Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You are over 50 years old
• You have been diagnosed with a type of age-related macular degeneration (AMD) that involves abnormal blood vessel growth (called neovascular AMD) affecting the central part of your retina
• You may be either new to treatment or have had treatment before and the condition has returned
• There is no minimum or maximum vision level required to take part
• The abnormal blood vessels must currently be active and located under the central part of your retina (confirm with trial site)

Who may not be able to join:

• You have received anti-VEGF eye injections (a common treatment for eye conditions) in the last six months
• You have another eye condition such as diabetic macular oedema, retinal vein occlusion, central serous chorioretinopathy, or short-sightedness-related abnormal blood vessel growth
• You have had certain types of laser treatment to the central part of your eye, or eye surgery such as cataract surgery or a procedure called vitrectomy, in the last six months or during the study period (note: a specific light-based treatment called photodynamic therapy does not disqualify you)

Important: Always verify eligibility with the trial site directly before applying.